Straumann Holding AG Debt to Equity Ratio 2012-2024 | SAUHY

Current and historical debt to equity ratio values for Straumann Holding AG (SAUHY) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Straumann Holding AG debt/equity for the three months ending December 31, 2024 was 0.00.
Straumann Holding AG Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $1.79B $2.32B 0.77
2024-06-30 $1.67B $2.18B 0.76
2023-12-31 $1.65B $2.05B 0.81
2022-12-31 $1.59B $1.94B 0.82
2021-12-31 $1.61B $1.64B 0.98
2021-06-30 $1.59B $1.50B 1.06
2020-12-31 $1.43B $1.29B 1.11
2020-06-30 $1.17B $1.10B 1.06
2019-12-31 $1.03B $1.38B 0.75
2018-12-31 $0.68B $1.23B 0.55
2017-12-31 $0.62B $1.09B 0.57
2017-06-30 $0.54B $0.66B 0.81
2016-12-31 $0.46B $0.64B 0.72
2016-06-30 $0.48B $0.75B 0.64
2015-12-31 $0.46B $0.63B 0.73
2014-12-31 $0.46B $0.81B 0.58
2013-12-31 $0.42B $0.68B 0.62
2013-06-30 $0.38B $0.64B 0.60
2012-12-31 $0.15B $0.67B 0.22
2012-06-30 $0.18B $0.69B 0.26
2011-12-31 $0.16B $0.76B 0.21
Sector Industry Market Cap Revenue
Medical MED/DENTAL-SUPP $19.454B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) US $88.577B 24.24
Becton Dickinson (BDX) US $48.681B 12.03
Cardinal Health (CAH) US $35.155B 18.19
Labcorp (LH) US $20.195B 16.38
Cooper (COO) US $16.226B 21.52
West Pharmaceutical Services (WST) US $15.106B 31.67
Align Technology (ALGN) US $12.939B 25.43
Henry Schein (HSIC) US $7.897B 13.60
Merit Medical Systems (MMSI) US $5.508B 26.63
DENTSPLY SIRONA (XRAY) US $2.776B 8.34
CONMED (CNMD) US $1.769B 13.24
STAAR Surgical (STAA) US $0.908B 0.00
Pro-Dex (PDEX) US $0.219B 24.04
Lifevantage (LFVN) US $0.147B 16.26